Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,220,216
-
Share change
-
+602,908
-
Total reported value
-
$43,629,382
-
Put/Call ratio
-
35%
-
Price per share
-
$2.69
-
Number of holders
-
58
-
Value change
-
+$972,348
-
Number of buys
-
30
-
Number of sells
-
31
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q2 2016
As of 30 Jun 2016 ACELRX PHARMACEUTICALS INC - COM (ACRX) had 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,220,216 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Palo Alto Investors, LLC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, STATE STREET CORP, NORTHERN TRUST CORP, DEUTSCHE BANK AG\, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This table shows 58 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.